FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2082057100> ?p ?o ?g. }

• W2082057100 endingPage "e36856" @default.
• W2082057100 startingPage "e36856" @default.
• W2082057100 abstract "PI3K/AKT signalling pathway is aberrantly active and plays a critical role for cell cycle progression of human malignant pleural mesothelioma (MMe) cells. AKT is one of the important cellular targets of perifosine, a novel bio-available alkylphospholipid that has displayed significant anti-proliferative activity in vitro and in vivo in several human tumour model systems and is currently being tested in clinical trials.We tested Perifosine activity on human mesothelial cells and different mesothelioma cell lines, in order to provide evidence of its efficacy as single agent and combined therapy.We demonstrate here that perifosine, currently being evaluated as an anti-cancer agent in phase 1 and 2 clinical trials, caused a dose-dependent reduction of AKT activation, at concentrations causing MMe cell growth arrest. In this study we firstly describe that MMe cells express aside from AKT1 also AKT3 and that either the myristoylated, constitutively active, forms of the two proteins, abrogated perifosine-mediated cell growth inhibition. Moreover, we describe here a novel mechanism of perifosine that interferes, upstream of AKT, affecting EGFR and MET phosphorylation. Finally, we demonstrate a significant increase in cell toxicity when MMe cells were treated with perifosine in combination with cisplatin.This study provides a novel mechanism of action of perifosine, directly inhibiting EGFR/MET-AKT1/3 axis, providing a rationale for a novel translational approach to the treatment of MMe." @default.
• W2082057100 created "2016-06-24" @default.
• W2082057100 creator A5011424716 @default.
• W2082057100 creator A5019310092 @default.
• W2082057100 creator A5067320886 @default.
• W2082057100 creator A5084519811 @default.
• W2082057100 creator A5085799356 @default.
• W2082057100 date "2012-05-10" @default.
• W2082057100 modified "2023-09-27" @default.
• W2082057100 title "Perifosine as a Potential Novel Anti-Cancer Agent Inhibits EGFR/MET-AKT Axis in Malignant Pleural Mesothelioma" @default.
• W2082057100 cites W1529396499 @default.
• W2082057100 cites W1568605582 @default.
• W2082057100 cites W1966803171 @default.
• W2082057100 cites W1969134590 @default.
• W2082057100 cites W1987709860 @default.
• W2082057100 cites W1991566510 @default.
• W2082057100 cites W1999036451 @default.
• W2082057100 cites W2014415600 @default.
• W2082057100 cites W2045400845 @default.
• W2082057100 cites W2064401078 @default.
• W2082057100 cites W2067837009 @default.
• W2082057100 cites W2072791233 @default.
• W2082057100 cites W2096763507 @default.
• W2082057100 cites W2099110265 @default.
• W2082057100 cites W2102353246 @default.
• W2082057100 cites W2111264921 @default.
• W2082057100 cites W2122471672 @default.
• W2082057100 cites W2125169413 @default.
• W2082057100 cites W2125760011 @default.
• W2082057100 cites W2131561057 @default.
• W2082057100 cites W2136390065 @default.
• W2082057100 cites W2152529513 @default.
• W2082057100 cites W2170745030 @default.
• W2082057100 doi "https://doi.org/10.1371/journal.pone.0036856" @default.
• W2082057100 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3349630" @default.
• W2082057100 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22590625" @default.
• W2082057100 hasPublicationYear "2012" @default.
• W2082057100 type Work @default.
• W2082057100 sameAs 2082057100 @default.
• W2082057100 citedByCount "35" @default.
• W2082057100 countsByYear W20820571002012 @default.
• W2082057100 countsByYear W20820571002013 @default.
• W2082057100 countsByYear W20820571002014 @default.
• W2082057100 countsByYear W20820571002015 @default.
• W2082057100 countsByYear W20820571002016 @default.
• W2082057100 countsByYear W20820571002017 @default.
• W2082057100 countsByYear W20820571002018 @default.
• W2082057100 countsByYear W20820571002019 @default.
• W2082057100 countsByYear W20820571002021 @default.
• W2082057100 countsByYear W20820571002022 @default.
• W2082057100 crossrefType "journal-article" @default.
• W2082057100 hasAuthorship W2082057100A5011424716 @default.
• W2082057100 hasAuthorship W2082057100A5019310092 @default.
• W2082057100 hasAuthorship W2082057100A5067320886 @default.
• W2082057100 hasAuthorship W2082057100A5084519811 @default.
• W2082057100 hasAuthorship W2082057100A5085799356 @default.
• W2082057100 hasBestOaLocation W20820571001 @default.
• W2082057100 hasConcept C11960822 @default.
• W2082057100 hasConcept C142724271 @default.
• W2082057100 hasConcept C154137905 @default.
• W2082057100 hasConcept C185592680 @default.
• W2082057100 hasConcept C2777407522 @default.
• W2082057100 hasConcept C502942594 @default.
• W2082057100 hasConcept C55493867 @default.
• W2082057100 hasConcept C62112901 @default.
• W2082057100 hasConcept C62478195 @default.
• W2082057100 hasConcept C71924100 @default.
• W2082057100 hasConcept C75217442 @default.
• W2082057100 hasConcept C86554907 @default.
• W2082057100 hasConcept C86803240 @default.
• W2082057100 hasConcept C88216763 @default.
• W2082057100 hasConcept C95444343 @default.
• W2082057100 hasConceptScore W2082057100C11960822 @default.
• W2082057100 hasConceptScore W2082057100C142724271 @default.
• W2082057100 hasConceptScore W2082057100C154137905 @default.
• W2082057100 hasConceptScore W2082057100C185592680 @default.
• W2082057100 hasConceptScore W2082057100C2777407522 @default.
• W2082057100 hasConceptScore W2082057100C502942594 @default.
• W2082057100 hasConceptScore W2082057100C55493867 @default.
• W2082057100 hasConceptScore W2082057100C62112901 @default.
• W2082057100 hasConceptScore W2082057100C62478195 @default.
• W2082057100 hasConceptScore W2082057100C71924100 @default.
• W2082057100 hasConceptScore W2082057100C75217442 @default.
• W2082057100 hasConceptScore W2082057100C86554907 @default.
• W2082057100 hasConceptScore W2082057100C86803240 @default.
• W2082057100 hasConceptScore W2082057100C88216763 @default.
• W2082057100 hasConceptScore W2082057100C95444343 @default.
• W2082057100 hasIssue "5" @default.
• W2082057100 hasLocation W20820571001 @default.
• W2082057100 hasLocation W20820571002 @default.
• W2082057100 hasLocation W20820571003 @default.
• W2082057100 hasLocation W20820571004 @default.
• W2082057100 hasLocation W20820571005 @default.
• W2082057100 hasOpenAccess W2082057100 @default.
• W2082057100 hasPrimaryLocation W20820571001 @default.
• W2082057100 hasRelatedWork W1556314914 @default.
• W2082057100 hasRelatedWork W1988747615 @default.
• W2082057100 hasRelatedWork W2000036071 @default.

• next